Webinar Pre-Test, Update on EC: Frequently Asked Questions (Part 3/3)

Pre-Test

Please take a minute to complete this pre-session survey both to gauge your existing knowledge of the subject matter in advance of the webinar (necessary to award of CME/CE credits) and also to help ARHP assess the impact of its educational programs. Completing this survey will provide ARHP with an invaluable tool for understanding how health professionals use educational offerings and how ARHP activities might be improved to serve you better.

Question Title

* 1. Today's date (MM/DD/YYYY):

Date

Question Title

* 2. Your primary professional category (choose the one best response):

Health Professional Educator

Nurse Midwife

Nurse Practitioner

Pharmacist

Physician

Physician Assistant

Registered Nurse

Resident

Student

Other (please specify)

Question Title

* 3. Do you interact with patients?

Yes

Question Title

* 4. How did you hear about this ARHP educational activity? (Please check all that apply.)

From an email from ARHP

From the ARHP website

From a colleague or friend

From social media (Facebook, Twitter, LinkedIn)

Other (please specify)

Question Title

* 5. What is the minimum age required to purchase levonorgestrel EC products without a prescription?

A. 16

B. 17

C. 18

D. There's no age restriction

Question Title

* 6. Which of the following medications could interact with UPA EC? (Check all that apply)

A. Progestin-containing contraceptives

B. Aspirin

C. Hepatic (CYP450) enzyme inducers (St. John’s Wort, rifampicin, anti-convulsants)

D. Statins

Question Title

* 7. Some breastfeeding women may not need EC (or any contraception) because lactational amenorrhea is likely to prevent pregnancy. What criteria should be met for lactational amenorrhea to be considered effective? (Check all that apply)

A. Baby is less than 6 months old

B. Exclusively breastfeeding

C. Pumping on a regular schedule

D. Period has not returned

Question Title

* 8. Can the weight of the user reduce the efficacy of EC? If so, which EC methods could be affected? (Check all that apply)

A. LNG EC pills

B. Copper IUD

C. UPA EC pills

D. None of these

Question Title

* 9. As a result of participating in this activity, I hope to be better able to:

Thank you for completing this pre-session questionnaire. Please see the reminder e-mail for complete instructions on how to access the webinar. If you have any questions, please contact education@arhp.org.